Nutrients · 2020 · 41 citations · 42 references
AgricultureNutritionNutritional SciencesClinical NutritionHuman NutritionNutritional BiochemistryBioactive Food ComponentsBiomarkers Of Liver InjuryEssential Fatty AcidsLiver DiseaseNutrition In Liver DiseaseDocosahexaenoic AcidFatty AcidsFish Oil SupplementationLiver Fibrosis BiomarkersLiver Fibrosis ProgressionPilot Study DesignPlacebo-controlled Efficacy AssessmentUnsaturated Fatty Acids
Non-alcoholic fatty liver disease (NAFLD) is a chronic disease affecting up to 25% of the population worldwide. n-3 long-chain polyunsaturated fatty acids (n-3 PUFA) have been associated with improved clinical parameters of NAFLD. Our purpose was to conduct a pilot study to evaluate the effects of n-3 PUFA supplementation in a randomized, double-blind, placebo-controlled clinical study performed on NAFLD individuals diagnosed by ultrasound. Patients received n-3 PUFA (n = 13) or placebo (n = 11) supplementation for six months. Circulating miR-122 expression (determined by quantitative real time-polymerase chain reaction (qRT-PCR), liver fibrosis (FibroScan®), red blood cells (RBC) fatty acids (gas chromatography), and biochemical tests were performed at baseline and after intervention. After the intervention, in the n-3 PUFA group, docosahexaenoic acid (DHA) and omega index increased significantly in RBC (p = 0.022 and p = 0.012, respectively), in addition to a significant reduction in alkaline phosphatase (ALP) (p = 0.002) and liver fibrosis (p = 0.039). However, there was no change in the expression of circulating miR-122 in both groups. Our results showed that omega-3 PUFA were incorporated in erythrocytes after six months of fish oil supplementary intake, and that n-3 PUFA were effective in reducing ALP and liver fibrosis without altering the expression of circulating miR-122 in individuals with NAFLD.
42
Identification of Tissue-Specific MicroRNAs from Mouse
Mariana Lagos‐Quintana, Reinhard Rauhut, Abdullah Yalçın et al. · Current Biology · 2002 · 3.3K citations · Full text
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
Christine Esau, Scott Davis, Susan Murray et al. · Cell Metabolism · 2006 · 2.1K citations · Full text
Peter Eddowes, M. Sasso, Michael Allison et al. · Gastroenterology · 2019 · 1.4K citations · Full text